mother.

The potential risk of apnoea and the need for respiratory monitoring for 48 72h should be considered when administering the primary immunisation series to very premature infants (born 28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity.

4.5 Interaction with other medicinal products and other forms of interaction

co administration

The possible interaction with other substrates of this isozyme is unknown but should be considered for other medicinal products with a narrow therapeutic index, for example, antiarrhythmic agents Class III including amiodarone.

Alternative instru ments considered

This is something to consider.

I've taken everything into consideration.

Tom considered it.

Mary considered it.

Moreover, in case of withdrawal of glucocorticoids progressive dose reduction may have to be performed over a longer period.

Moreover, in case of withdrawal of glucocorticoids progressive dose reduction may have to be performed over a longer period.

They took every possibility into consideration.

We've allowed for that possibility.

There is a need for greater transparency and flexibility in our intervention system for beef, which might well lead to not insignificant savings.

This is exactly what we have taken into consideration.

500 μ g, 300 μ g, and 150 μ g should be considered. a

Other possible approaches are under consideration as well.

In evaluating patients for infections, the patient s risk for relevant opportunistic infections (e. g., exposure to endemic mycoses) should be considered.

In evaluating patients for infections, the patient s risk for relevant opportunistic infections (e. g., exposure to endemic mycoses) should be considered.

Appropriate dose titration should be considered.

er predominantly reported in patients with CRF treated subcutaneously.

Concomitant use to take into consideration

Transfer to a therapy that is recommended at the severe stage of the disease (e. g., epoprostenol) should be considered if the clinical condition deteriorates (see section 4.2).

Transfer to a therapy that is recommended at the severe stage of the disease (e.g., epoprostenol) should be considered if the clinical condition deteriorates (see section 4.2).

Alternative contraceptive measures should be considered.

Individual adjustment of dosage should be considered.

Combination therapy with gastro protective agents (e. g. misoprostol or proton pump inhibitors) should also be carefully considered for all patients and in particular for the elderly.

Given that piroxicam has been shown to be associated with an increased risk of gastrointestinal complications, the possible need for combination therapy with gastro protective agents (e. g. misoprostol or proton pump inhibitors) should be carefully considered, in particular for elderly patients .

I never even considered this.

4.2 The following indicators should be considered

Longer term partnerships should also be taken into consideration.

There are other possible solutions.

All these concerns need to be taken into account.

Deposit insurance is not even being considered.

I didn't consider the subject seriously.

I didn't even consider that.

Hospitalisation should be considered as appropriate.

er predominantly reported in patients with CRF treated subcutaneously.

Monitoring of renal function should be considered.

A dose reduction of buprenorphine may be considered

(c) Did the programme consider externalisation?

(i) Did the programme consider externalisation?

3.4 The following should be considered as general objectives

3.5 The following should be considered as specific objectives